INFECTIOUS MONONUCLEOSIS
Clinical trials for INFECTIOUS MONONUCLEOSIS explained in plain language.
Never miss a new study
Get alerted when new INFECTIOUS MONONUCLEOSIS trials appear
Sign up with your email to follow new studies for INFECTIOUS MONONUCLEOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a nanoparticle vaccine stop the virus behind mono and some cancers?
⭐️ VACCINE ⭐️ CompletedThis early-stage trial is testing whether a new vaccine can safely train the immune system to fight Epstein-Barr virus (EBV), which causes infectious mononucleosis and is linked to several cancers. Healthy adults aged 18 to 29, both with and without prior EBV infection, will rece…
Matched conditions: INFECTIOUS MONONUCLEOSIS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 24, 2026 00:00 UTC
-
Could a vaccine finally stop the 'Kissing Disease'?
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine designed to prevent Epstein-Barr virus (EBV) infection, which causes most cases of infectious mononucleosis (mono). Twenty-five healthy adults aged 18 to 25 who had never been infected with EBV received either the vaccine or a placebo. The goal was…
Matched conditions: INFECTIOUS MONONUCLEOSIS
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:23 UTC